Are you ready for the first ILCA Webinar of the year?

Benefits and risks of systemic therapy for patients with HCC awaiting liver transplantation

Tuesday, February 21st 2023
3:00 PM – 4:00 PM CET 

Register Now

We are excited to invite you to our first webinar of the year titled “Benefits and risks of systemic therapy for patients with HCC awaiting liver transplantation.” The topic is of significant importance to healthcare professionals dealing with liver cancer patients and our speakers will share their insights into various aspects of systemic therapy.

Webinar Chairs

Julie Heimbach, Director, William Von Liebig Center for Transplantation | Professor of Surgery | Mayo Clinic College of Medicine, USA

Olivier Rosmoduc, Hepatologist and liver oncologist in Hepato-Biliary Centre at Paul Brousse Hospital – Villejuif, France

Webinar Speakers

Myron Schwartz, Clinical Director of the Mount Sinai Liver Cancer Program, New York, USA, will present “Which patients to treat?“

Ahmed Kaseb, Professor, Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, will present “Which medications to use?“

Anjana Pillai, Medical Director of the multidisciplinary liver tumor program at UChicago Medicine, USA, will present “When to start and when to stop systemic therapy?“

Registration Details

Attend the Webinar

Eisai has funded the webinar and all content has been developed independently by ILCA